Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -135.20% | 37.42% | 9.77% | 52.34% | 80.02% |
| Total Depreciation and Amortization | -97.78% | -34.75% | 4.72% | -9.92% | -1.96% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.22% | 120.82% | 64.20% | -54.20% | -112.12% |
| Change in Net Operating Assets | 180.03% | -3.26% | 118.21% | -104.40% | 161.65% |
| Cash from Operations | -500.71% | 47.14% | 86.19% | -201.64% | 96.73% |
| Capital Expenditure | -- | -- | -- | -- | -67.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -2.56% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -100.00% | -23.13% |
| Total Debt Issued | -60.63% | -22.79% | -63.63% | 100.00% | -16.80% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.63% | -22.79% | -66.14% | 100.00% | -52.18% |
| Foreign Exchange rate Adjustments | 103.18% | -104.06% | 4.45% | 1,277.78% | -92.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.67% | -17.86% | -190.00% | 110.64% | 101.35% |